Strata Critical Medical, Inc.
SRTA
$5.19
$0.163.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.98M | -26.57M | -27.31M | -51.46M | -49.21M |
| Total Depreciation and Amortization | 6.28M | 6.07M | 5.96M | 6.24M | 6.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.64M | 23.39M | 21.84M | 38.27M | 29.80M |
| Change in Net Operating Assets | -2.64M | 9.90M | -3.01M | -3.14M | -1.80M |
| Cash from Operations | 1.29M | 12.79M | -2.52M | -10.09M | -14.42M |
| Capital Expenditure | -18.81M | -32.68M | -30.88M | -26.32M | -17.70M |
| Sale of Property, Plant, and Equipment | 82.00K | 18.00K | 13.00K | 144.00K | 138.00K |
| Cash Acquisitions | -2.23M | -2.23M | -2.23M | -2.23M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.38M | 29.72M | 32.08M | 23.49M | 22.25M |
| Cash from Investing | 40.42M | -5.17M | -1.02M | -4.92M | 4.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 129.00K | 137.00K | 168.00K | 131.00K | 129.00K |
| Repurchase of Common Stock | -10.12M | -10.20M | -5.93M | -2.04M | -1.31M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9.99M | -10.06M | -5.76M | -1.91M | -1.18M |
| Foreign Exchange rate Adjustments | 230.00K | 72.00K | -80.00K | 44.00K | -119.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.95M | -2.37M | -9.37M | -16.87M | -11.03M |